Krystal Biotech CEO Krishnan Krish S sold 25,000 shares at prices ranging from $354.54 to $366.56 per share. After the transactions, he owned 1,347,543 shares, giving investors a specific view of his remaining ownership in the biotechnology company following the reported insider sale.

Key Highlights

  • The transactions took place on Sep. 4, 2026.
  • Krishnan Krish S held 1,347,543 shares after the transactions.
  • Krishnan Suma, President of R&D, was also identified as selling 25,000 shares at the stated price range.

Krystal Biotech, Inc. (NASDAQ: KRYS) President and CEO Krishnan Krish S sold 25,000 shares at prices ranging from $354.54 to $366.56 per share. The transactions occurred on Sep. 4, 2026.

Krystal Biotech Sale Details

The reported sales were recorded under SEC transaction code S. The filing reports prices ranging from $354.54 to $366.56 per share across the transactions. The transaction details identify Krishnan Suma, the company’s President of R&D, as also selling 25,000 shares across the stated price range.

Remaining Insider Ownership

Krishnan Krish S’s post-transaction holding was 1,347,543 shares. That figure represents his ownership after the reported sales.